| Redox regulation in the base excision repair pathway: old and new players as cancer therapeutic targets A Rajapakse, A Suraweera, D Boucher, A Naqi, K O'Byrne, DJ Richard, ... Current Medicinal Chemistry 27 (12), 1901-1921, 2020 | 11 | 2020 |
| Pharmacological targeting of STING-dependent IL-6 production in cancer cells SS Al-Asmari, A Rajapakse, TR Ullah, G Pépin, LV Croft, MP Gantier Frontiers in Cell and Developmental Biology 9, 709618, 2022 | 10 | 2022 |
| Unilateral autoimmune inner ear disease in a patient with lung cancer treated with nivolumab A Rajapakse, C O’Leary, R Gundelach, R Deva, K O’Byrne Oxford Medical Case Reports 2020 (9), omaa077, 2020 | 8 | 2020 |
| 1153P A first in class DNA repair inhibitor for the treatment of NSCLC D Boucher, L Croft, S Beard, IM Najib, A Rajapakse, P Duijf, DJ Richard, ... Annals of Oncology 33, S1076-S1077, 2022 | 1 | 2022 |
| Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2′-O-Methyl Modified Single-Stranded Oligonucleotides LV Croft, M Fisher, TK Barbhuiya, S El-Kamand, S Beard, A Rajapakse, ... nucleic acid therapeutics, 2024 | | 2024 |
| Epidermal growth factor potentiates EGFR (Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium P Wang, R Zhou, R Zhou, S Feng, L Zhao, W Li, J Lin, A Rajapakse, ... Redox Biology 69, 102976, 2024 | | 2024 |
